The 9th Asian Informal Drug Policy Dialogue. Transnational Institute. (2018)

immage

In regards to current drug trends, particularly methamphetamine (both in crystal and pill form) has become increasingly accessible and affordable throughout Asia, reflecting the trend of rising use of amphetamine-type stimulants (ATS) in the region.

Governments in the SEA region have implemented different kinds of national drug policy reform, including diversion programmes (Indonesia and Cambodia), harm reduction measures (Malaysia and Myanmar), and steps towards decriminalisation of cannabis cultivation and use for medical and scientific purposes (Thailand).

 


Keywords: community, harm reduction, treatment, drugs

 

Download Publication

The Lost Decade: Neglect for Harm Reduction Funding and the Health Crisis among People who Use Drugs. Cook C and Davies C. (2018)

immage

In Harm Reduction International’s 2010 report on the state of global funding for harm reduction, we stressed, ‘more money is needed for harm reduction, and it is needed now’. Sadly, this statement remains true in 2018. Harm reduction interventions for people who use drugs—such as needle and syringe programmes (NSP) and opioid substitution therapy (OST)—are cost-effective, protect against HIV and hepatitis C, and save lives. Despite the potential for these interventions to contribute to healthier communities, funding for harm reduction in lowand middle-income countries (LMICs) has flat-lined over the past decade.

 


Keywords: HIV/AIDS, LMICs, harm reduction, funding

 

 

Download Publication

When Situations Go from Bad to Worse: Guidance For International And Regional Actors Responding To Acute Violence Against Key Populations. LINKAGES Project. (2018)

immage

As the violence directed at members of key populations most affected by HIV — gay, bisexual, and other men who have sex with men; people who inject drugs; sex workers; and transgender people — intensifies and becomes “acute” in many parts of the globe, this brief offers guidance to international and regional actors who wish to be part of an effective and coordinated response. International and regional actors who may benefit from this guidance include, but are not limited to, key population networks, governmental bodies, donors, embassies, security experts, nongovernmental organizations (NGOs), media, research institutions, United Nations (UN) agencies or offices, and human rights organizations operating globally or regionally.


Keywords: HIV, violence, key populations, human rights

 

Download Publication

World Drug Report 2018. UNODC. (2018)

immage

Following last year's 20th anniversary edition, the World Drug Report 2018 is again presented in a special five-booklet format designed to enhance reader friendliness while maintaining the wealth of information contained within. Booklet 1 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. Booklet 2 provides a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs. Booklet 3 examines current estimates of and trends in the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis), reviews the latest developments in cannabis policies and provides an analysis of the global synthetic drugs market, including new psychoactive substances. Booklet 4 looks at the extent of drug use across age groups, particularly among young and older people, by reviewing the risks and vulnerabilities to drug use in young people, the health and social consequences they experience and their role in drug supply, as well as highlighting issues related to the health care needs of older people who use drugs. Finally, Booklet 5 focuses on the specific issues related to drug use among women, including the social and health consequences of drug use and access to treatment by women with drug use disorders; it also discusses the role played by women in the drug supply chain.

 

Keywords: drugs, women, young people, prisoners, health care, treatment

 

Download Reports 


- Booklet 1: Executive Summary - Conclusions and Policy Implications


- Booklet 2: Global Overview of Drug Demand and Supply


- Booklet 3: Analysis of Drug Markets - Opioids, Cocaine, Cannabis, Synthetic Drugs


- Booklet 4: Drugs and Age - Drugs and Associated Issues among Young People and Older People


- Booklet 5: Women and Drugs - Drug Use, Drug Supply and Their Consequences


- World Drug Report 2018 - Presentation
 

A Handbook for Starting and Managing Needle and Syringe Programmes in Prisons and Other Closed Settings. UNODC. (2017)

immage

To successfully address HIV and hepatitis where injecting drug use occurs, countries should prioritize implementing NSPs and evidence-based drug dependence treatment (specifically OST), HIV testing and counselling and access to antiretroviral therapy.

Needle and syringe programmes (NSP) provide access to sterile injecting equipment to people who inject illicit drugs to prevent the transmission of HIV and hepatitis B and C through shared injection equipment.

 

Keywords: PWID, HIV, harm reduction, prevention, prisoners

 

Download Publication

Addressing Drug Problems in Myanmar. Transnational Institute (TNI). (2017)

immage

This policy briefing was drafted by a group of local and international organisations with in-depth knowledge and extensive experience of drug-related issues in Myanmar. It is structured around a set of five strategic interventions, each of which comes with concrete recommendations that are adapted to the Myanmar context. It contains reliable, up-to-date information and examples of evidence-based practices from Myanmar and around the world.


Keywords: harm reduction, discrimination, civil engagement, health

 

Download Publication

Factsheet: HARiS - HIV and AIDS Response Indicator Survey 2016 for Injecting Drug User. Centre for Health Protection, Department of Health. (2017)

immage

In Hong Kong, the number of HIV cases transmitted through injecting drug use (IDU) has remained low up till now and contributed to less than 5% of all reported cases cumulatively. However, the potential risk of cluster outbreak and rapid upsurge of infection among the IDU population is always a concern. To monitor HIV-related risk behaviours and access to HIV testing services among IDU, this population has been included as one of the four at-risk populations in the HIV/AIDS Response Indicator Survey (HARiS) implemented since 2013. The fourth round of survey was conducted in 2016 via commissioning to the Stanley Ho Centre for Emerging Infectious Disease, School of Public Health and Primary Care of the Chinese University of Hong Kong.


Keywords: Hong Kong, HIV, IDU, STI, sexual behaviours, testing, needle, condom

 

Download Publication

 

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users (FIDUs) in Pokhara Valley - Round I, 2017. National Centre for AIDS and STD Control. (2017)

immage

This is the first round of the IBBS survey conducted among Female Injecting Drug Users (FIDUs) in Pokhara Valley. The females of 16 years and above who had been injecting drugs for at least three months preceding the survey were defined as FIDUs and enrolled in the survey. School of Planning Monitoring Evaluation and Research (SPMER) carried out this survey from December 2016 to May 2017 under the leadership of NCASC. The survey was undertaken primarily to determine the prevalence of HIV, Syphilis, Hepatitis B (HBV) and Hepatitis C (HCV) infection among FIDUs.


Keywords: Nepal, prevalence, syringe/needles, treatment, condom use, knowledge, testing

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWIDs) in Eastern Terai Highway Districts of Nepal, 2017 (Round VII). National Centre for AIDS and STD Control. (2017)

immage

This Integrated Biological and Behavioral Surveillance (IBBS) survey was carried out by Intrepid Nepal (INPL) under the leadership of the National Center for AIDS and STD Control (NCASC). People Who Inject Drugs (PWIDS) is considered as one of the key affected populations (KAPs) at a higher risk of spreading the HIV epidemic. This is the seven round of the IBBS study conducted among PWID s in Eastern Teri highway districts of Nepal.

 

Keywords: HIV, PWID, STI, HCV, HBV, syphilis, condom

 

Download Publication

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWIDs) in Western Terai Highway Districts of Nepal, 2017 (Round VI). National Centre for AIDS and STD Control. (2017)

immage

This Integrated Biological and Behavioral Surveillance (IBBS) survey was carried out by Intrepid Nepal (INPL) under the leadership of the National Center for AIDS and STD Control (NCASC). People Who Inject Drugs (PWIDS) is considered as one of the key affected populations (KAPs) at a higher risk of spreading the HIV epidemic. This is the seven round of the IBBS study conducted among PWID s in Eastern Teri highway districts of Nepal.

 

Keywords: HIV, PWID, HCV, HBV, STI, condom

 

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
Calendar of events
Oct
11
Nov
14
Nov
20